|1.65|| +0.05 / +3.12%|
Services to the Health Industry
Bioanalytical Systems, Inc. operates as a pharmaceutical development company which, provides drug discovery, development services and analytical instruments. It supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The company operates through two business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. Bioanalytical Systems was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
|Jacqueline M. Lemke||President, Chief Executive Officer & Director|
|Jill Blumhoff||Director-Finance & Information Technology|
|Jeffrey Potrzebowski||CFO, VP-Finance & Head-Investor Relations|
|Philip A. Downing||Vice President-Preclinical Services|
|James Sevall Bourdage||Vice President-Bioanalytical Operations|